Shanshan Ma

Dr. Shanshan Ma


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2022 in eLife
Verified
Journal Article
Open access
WCWeizhao Chen
Weizhao Chen
QZQiongping Zheng
Qiongping Zheng
QHQiaoying Huang
Qiaoying Huang
SMShanshan Ma
Shanshan Ma
MLMingtao Li
Mingtao Li
Lineage reprogramming of resident glial cells to dopaminergic neurons (DAns) is an attractive prospect of the cell-replacement therapy for Parkinson’s disease (PD). However, it is unclear whether repressing polypyrimidine tract binding protein 1 (PTBP1) could efficiently convert astrocyte to DAns in the substantia nigra and striatum. Although reporter-positive DAns were observed in both groups after delivering the adeno-associated virus (AAV) expressing a reporter with shRNA or CRISPR-CasRx to repress astroglial PTBP1, the possibility of AAV leaking into endogenous DAns could not be excluded without using a reliable lineage-tracing method. By adopting stringent lineage-tracing strategy, two other studies show that either knockdown or genetic deletion of quiescent astroglial PTBP1 fails to obtain induced DAns under physiological condition. However, the role of reactive astrocytes might be underestimated because upon brain injury, reactive astrocyte can acquire certain stem cell hallmarks that may facilitate the lineage conversion process. Therefore, whether reactive astrocytes could be genuinely converted to DAns after PTBP1 repression in a PD model needs further validation. In this study, we used Aldh1l1-CreERT2-mediated specific astrocyte-lineage-tracing method to investigate whether reactive astrocytes could be converted to DAns in a 6-hydroxydopamine (6-OHDA) mouse model of PD. However, we found that no astrocyte-originated DAn was generated after effective and persistent knockdown of astroglial PTBP1 either in the substantia nigra or in striatum, while AAV ‘leakage’ to nearby neurons was easily observed. Our results confirm that repressing PTBP1 does not convert astrocytes to DAns, regardless of physiological or PD-related pathological conditions.

1 May 2009 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
ZYZhongmin Yuan
Zhongmin Yuan
SGShoufang Gong
Shoufang Gong
JLJingyan Luo
Jingyan Luo
ZZZhihao Zheng
Zhihao Zheng
BSBin Song
Bin Song
MLMingtao Li
Mingtao Li
The activator protein 1 (AP-1) transcription factor c-Jun is crucial for neuronal apoptosis. However, c-Jun dimerization partners and the regulation of these proteins in neuronal apoptosis remain unknown. Here we report that c-Jun-mediated neuronal apoptosis requires the concomitant activation of activating transcription factor-2 (ATF2) and downregulation of c-Fos. Furthermore, we have observed that c-Jun predominantly heterodimerizes with ATF2 and that the c-Jun/ATF2 complex promotes apoptosis by triggering ATF activity. Inhibition of c-Jun/ATF2 heterodimerization using dominant negative mutants, small hairpin RNAs, or decoy oligonucleotides was able to rescue neurons from apoptosis, whereas constitutively active ATF2 and c-Jun mutants were found to synergistically stimulate apoptosis. Bimolecular fluorescence complementation analysis confirmed that, in living neurons, c-Fos downregulation facilitates c-Jun/ATF2 heterodimerization. A chromatin immunoprecipitation assay also revealed that c-Fos expression prevents the binding of c-Jun/ATF2 heterodimers to conserved ATF sites. Moreover, the presence of c-Fos is able to suppress the expression of c-Jun/ATF2-mediated target genes and, therefore, apoptosis. Taken together, our findings provide evidence that potassium deprivation-induced neuronal apoptosis is mediated by concurrent upregulation of c-Jun/ATF2 heterodimerization and downregulation of c-Fos expression. This paradigm demonstrates opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis.


26 January 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YWYanna Wu
Yanna Wu
SMShanshan Ma
Shanshan Ma
YXYong Xia
Yong Xia
YLYangpeng Lu
Yangpeng Lu
SXShiyin Xiao
Shiyin Xiao
ZYZhongmin Yuan
Zhongmin Yuan
Cellular acetylation homeostasis is a kinetic balance precisely controlled by histone acetyl-transferase (HAT) and histone deacetylase (HDAC) activities. The loss of the counterbalancing function of basal HAT activity alters the precious HAT:HDAC balance towards enhanced histone deacetylation, resulting in a loss of acetylation homeostasis, which is closely associated with neuronal apoptosis. However, the critical HAT member whose activity loss contributes to neuronal apoptosis remains to be identified. In this study, we found that inactivation of GCN5 by either pharmacological inhibitors, such as CPTH2 and MB-3, or by inactivation with siRNAs leads to a typical apoptosis in cultured cerebellar granule neurons. Mechanistically, the BH3-only protein Bim is transcriptionally upregulated by activated Egr-1 and E2F1 and mediates apoptosis following GCN5 inhibition. Furthermore, in the activity withdrawal- or glutamate-evoked neuronal apoptosis models, GCN5 loses its activity, in contrast to Bim induction. Adenovirus-mediated overexpression of GCN5 suppresses Bim induction and apoptosis. Interestingly, the loss of GCN5 activity and the induction of Egr-1, E2F1 and Bim are involved in the early brain injury (EBI) following subarachnoid haemorrhage (SAH) in rats. HDAC inhibition not only significantly rescues Bim expression and apoptosis induced by either potassium deprivation or GCN5 inactivation but also ameliorates these events and EBI in SAH rats. Taken together, our results highlight a new mechanism by which the loss of GCN5 activity promotes neuronal apoptosis through the transcriptional upregulation of Bim, which is probably a critical event in triggering neuronal death when cellular acetylation homeostasis is impaired.

1 March 2016 in Experimental Neurology
Verified
Journal Article
Closed access
QHQiaoying Huang
Qiaoying Huang
XDXiaoxiao Du
Xiaoxiao Du
XHXin He
Xin He
QYQing Yu
Qing Yu
KHKunhua Hu
Kunhua Hu
MLMingtao Li
Mingtao Li

7 March 2013 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MTMinghui Tan
Minghui Tan
SMShanshan Ma
Shanshan Ma
QHQiaoying Huang
Qiaoying Huang
KHKunhua Hu
Kunhua Hu
BSBin Song
Bin Song
MLMingtao Li
Mingtao Li
Neuronal activity shapes the dendritic arbour; however, most of the molecular players in this process remain to be identified. We observed that depolarization‐induced neuronal activity causes an increase in the phosphorylation of glycogen synthase kinase‐3 (GSK‐3)α/β on Ser21/9 in cerebellar granule neurons. Using several approaches, including gene knockdown and GSK‐3α/βS21A/S21A/S9A/S9A double knockin mice, we demonstrated that both GSK‐3β and GSK‐3α mediate activity‐dependent dendritic growth and that Ser21/9 phosphorylation of GSK‐3α/β plays an important role in this process. Collapsin response mediator protein‐2 (CRMP‐2), which is crucial for axon development, is phosphorylated at Thr514 and inactivated by GSK‐3. We found CRMP‐2 was located mainly in the dendrites of cerebellar granule neurons, in contrast to the axonal distribution in hippocampal neurons. Over‐expression of CRMP‐2 promoted and knockdown of CRMP‐2 impaired dendritic growth, suggesting that CRMP‐2 is necessary and sufficient for activity‐dependent dendritic development. Furthermore, silencing CRMP‐2 completely blocked the dendritic growth‐promoting effects of GSK‐3 knockdown, and expression of Thr514 nonphosphorylated form of CRMP‐2 counteracted the inhibitory effect of constitutively active GSK‐3. This data indicate that CRMP‐2 functions downstream of GSK‐3. Together, these findings identify a novel GSK‐3/CRMP‐2 pathway that connects neuronal activity to dendritic growth.